Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
D000243:Adenosine Deaminase / Q000172:deficiency* / Q000235:genetics / Q000302:isolation & purification; D058892:Adenosine Deaminase Inhibitors; D001803:Blood Transfusion; D002460:Cell Line; D003070:Coformycin / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000201:enzymology* / Q000378:metabolism / Q000628:therapy; D007166:Immunosuppressive Agents / Q000378:metabolism / Q000494:pharmacology; D007223:Infant; D008214:Lymphocytes / Q000201:enzymology / Q000378:metabolism; D008232:Lymphoproliferative Disorders / Q000188:drug therapy; D008297:Male; D009154:Mutation; D009700:Nucleoside Deaminases / Q000172:deficiency*; D015649:Pentostatin; D012333:RNA, Messenger / Q000378:metabolism
D058892:Adenosine Deaminase Inhibitors; D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D003070:Coformycin; D015649:Pentostatin; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase